Standardised measures to assess upper limb spasticity at baseline
| Standardised measure | Recorded at baseline | Recorded at follow-up | No. showing change | Correlation with GAS T-Score | |
|---|---|---|---|---|---|
| n (%)* | n (%)* | n (%) | r | p value | |
| Impairment | |||||
| Tardieu | 77 (16.9) | 62 (13.6) | 56 (90.3) | 0.43 | <0.001 |
| Active range of motion | 256 (56.1) | 231 (50.7) | 137 (59.3) | 0.41 | <0.001 |
| Passive range of motion | 248 (54.4) | 249 (54.6) | 172 (69.1) | 0.43 | <0.001 |
| Associated Reaction Rating Scale23 | 24 (5.3) | 26 (5.7) | 14 (53.8) | 0.76 | <0.001 |
| Symptoms/carer report | |||||
| Visual Analogue Scale† | 157 (34.4) | 139 (30.5) | 109 (78.4) | 0.46 | <0.001 |
| Function | |||||
| Leeds Adult Spasticity Impact Scale3 | 6 (1.3)‡ | 5 (1.1)‡ | — | — | |
| Arm Activity Scale24 | 27 (5.9) | 27 (5.9) | 14 (51.9) | 0.63 | <0.001 |
*Percentage of efficacy population.
†Parameters measured with VAS were not specified.
‡Numbers too small to compute.
GAS, goal attainment scaling.